Insider Transactions in Q2 2023 at Recursion Pharmaceuticals, Inc. (RXRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2023
|
Blake Borgeson Director |
SELL
Bona fide gift
|
Direct |
14,000
-0.19%
|
-
|
|
Jun 29
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.7%
|
$21,000
$7.49 P/Share
|
|
Jun 29
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.7%
|
$3,000
$1.06 P/Share
|
|
Jun 27
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$62,195
$7.39 P/Share
|
|
Jun 16
2023
|
Blake Borgeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+0.17%
|
-
|
|
Jun 16
2023
|
Robert Hershberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+24.62%
|
-
|
|
Jun 16
2023
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+15.23%
|
-
|
|
Jun 16
2023
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+1.94%
|
-
|
|
Jun 16
2023
|
R. Martin Chavez Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+19.82%
|
-
|
|
Jun 16
2023
|
Terry Ann Burrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,612
+6.84%
|
-
|
|
Jun 16
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-17.25%
|
$270,000
$9.41 P/Share
|
|
Jun 16
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.71%
|
$60,000
$2.22 P/Share
|
|
Jun 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
30,000
-17.25%
|
$270,000
$9.67 P/Share
|
|
Jun 15
2023
|
Shafique Virani Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+14.71%
|
$60,000
$2.22 P/Share
|
|
Jun 15
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.08%
|
-
|
|
Jun 15
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
10,000
+1.07%
|
-
|
|
Jun 14
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.97%
|
$250,000
$10.07 P/Share
|
|
Jun 14
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+4.26%
|
$75,000
$2.22 P/Share
|
|
Jun 13
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
15,485
-0.21%
|
$139,365
$9.98 P/Share
|
|
Jun 13
2023
|
Michael Secora Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.01%
|
$225,000
$9.93 P/Share
|
|
Jun 13
2023
|
Michael Secora Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+4.32%
|
$75,000
$2.22 P/Share
|
|
Jun 07
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
56,436
-5.8%
|
$507,924
$9.05 P/Share
|
|
Jun 07
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.11%
|
$62,500
$2.48 P/Share
|
|
Jun 02
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
17,865
-11.04%
|
$142,920
$8.93 P/Share
|
|
Jun 01
2023
|
David J Mauro Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190,713
+50.0%
|
-
|
|
Jun 01
2023
|
Shafique Virani Chief Business Officer |
SELL
Open market or private sale
|
Direct |
25,000
-13.38%
|
$200,000
$8.58 P/Share
|
|
May 31
2023
|
Tina Marriott Larson President and COO |
SELL
Open market or private sale
|
Direct |
3,000
-0.7%
|
$24,000
$8.63 P/Share
|
|
May 31
2023
|
Tina Marriott Larson President and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.7%
|
$3,000
$1.06 P/Share
|
|
May 30
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$71,080
$8.79 P/Share
|
|
May 16
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$44,425
$5.09 P/Share
|
|
May 15
2023
|
Shafique Virani Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,230
-1.19%
|
$11,150
$5.6 P/Share
|
|
May 15
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,661
-1.22%
|
$58,305
$5.6 P/Share
|
|
May 15
2023
|
Michael Secora Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,760
-0.6%
|
$23,800
$5.6 P/Share
|
|
May 15
2023
|
Tina Marriott Larson President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,415
-1.27%
|
$27,075
$5.6 P/Share
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
25,000
-100.0%
|
$100,000
$4.91 P/Share
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
25,000
+50.0%
|
-
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
33,073
-3.35%
|
$132,292
$4.71 P/Share
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.07%
|
$62,500
$2.48 P/Share
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-0.52%
|
-
|
|
May 03
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
1,338
+0.14%
|
-
|
|
Apr 21
2023
|
Dean Y Li Director |
SELL
Bona fide gift
|
Indirect |
627,705
-100.0%
|
-
|
|
Apr 18
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$44,425
$5.93 P/Share
|
|
Apr 06
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,000
-4.23%
|
$240,000
$6.64 P/Share
|
|
Apr 05
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
13,327
-1.39%
|
$79,962
$6.46 P/Share
|
|
Apr 05
2023
|
Christopher Gibson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+3.15%
|
$62,500
$2.48 P/Share
|
|
Apr 05
2023
|
Christopher Gibson Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
10,000
-1.07%
|
-
|
|
Apr 04
2023
|
Blake Borgeson Director |
SELL
Open market or private sale
|
Direct |
8,885
-0.12%
|
$53,310
$6.53 P/Share
|
|
Apr 03
2023
|
Zachary Bogue Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,542
+16.27%
|
-
|
|
Apr 03
2023
|
Zavain Dar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,996
+8.13%
|
-
|
|
Apr 03
2023
|
Dean Y Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,724
+0.28%
|
-
|